MYD88 and cardiac hypertrophy: CHRF also exerts its effects in various diseases through similar miRNA regulatory axes, including the CHRF/miR-489/MyD88 Axis, which is involved in cardiac hypertrophy, non-small cell lung cancer, and silicosis and is often associated with inflammatory responses, cell proliferation, and fibrosis.